ESC 365 - Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation

HFA Premium Access

Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation

Session: Cardio-oncology 3

Topic: Cardio-Oncology

Speaker: Doctor V. Dimitrova (Sofia, BG)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Veneta Dimitrova

University Hospital Alexandrovska, Sofia (Bulgaria)

2 presentations

0 follower

4 more presentations in this session

Multidisciplinary approach in cardio-oncology: putting words into action

Speaker: Doctor A. Pons Riverola (Barcelona, ES)

Levosimendan use in anthracycline-induced cardiomyopathy: reversing the irreversible ?

Speaker: Doctor V. Tassi (Athens, GR)

Immune checkpoint inhibitor-associated myocarditis: a rare presentation with electrical storm in a young patient with Hodgkin lymphoma

Speaker: Doctor A. Stavrati (Thessaloniki, GR)

Anthracycline chemotherapy-related cardiac dysfunction? It is not always what it seems

Speaker: Doctor H. Morillas Climent (Barcelona, ES) Doctor S. Jimenez-Marrero (Barcelona, ES)

Access the full session

Cardio-oncology 3

Speakers: Doctor V. Dimitrova, Doctor A. Pons Riverola, Doctor V. Tassi, Doctor A. Stavrati, Doctor H. Morillas Climent...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources